Henan Lingrui Pharmaceutical Co., Ltd. (SHA: 600285)
China
· Delayed Price · Currency is CNY 21.50
-0.01 (-0.05%)
Jan 7, 2025, 3:00 PM CST
Henan Lingrui Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 675.8 | 568.11 | 465.3 | 361.54 | 325.49 | 294.44 | Upgrade
|
| Depreciation & Amortization | 77.62 | 77.62 | 76.25 | 72.8 | 68.46 | 67.57 | Upgrade
|
| Other Amortization | 4.89 | 4.89 | 2.81 | 3.92 | 4.86 | 2.33 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.05 | -0.05 | -0.02 | -0.03 | -0.08 | 0.23 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.52 | 2.52 | 0.13 | 20.36 | 30.83 | 0.35 | Upgrade
|
| Loss (Gain) From Sale of Investments | -20.28 | -20.28 | -64.58 | -30.6 | -41.16 | 9.99 | Upgrade
|
| Provision & Write-off of Bad Debts | 4.64 | 4.64 | 1.99 | 2.07 | -0.48 | 1.33 | Upgrade
|
| Other Operating Activities | -262.5 | 3.83 | 5.82 | 12.17 | 1.73 | 13.11 | Upgrade
|
| Change in Accounts Receivable | -43.44 | -43.44 | -76.41 | 235.66 | -70.53 | -108.6 | Upgrade
|
| Change in Inventory | 26.9 | 26.9 | -58.19 | -105.69 | -44.51 | 36.79 | Upgrade
|
| Change in Accounts Payable | 197.7 | 197.7 | 477.76 | 261.4 | 194.99 | 136.85 | Upgrade
|
| Change in Other Net Operating Assets | 14.07 | 14.07 | 37.62 | 28.6 | - | - | Upgrade
|
| Operating Cash Flow | 654.79 | 813.43 | 834.91 | 845.69 | 450.53 | 450.15 | Upgrade
|
| Operating Cash Flow Growth | -24.31% | -2.57% | -1.27% | 87.71% | 0.08% | 3.19% | Upgrade
|
| Capital Expenditures | -43.86 | -21.2 | -26.99 | -76.91 | -71.82 | -59.04 | Upgrade
|
| Sale of Property, Plant & Equipment | 10.02 | 10.15 | 12.23 | 0.47 | 0.2 | 0.84 | Upgrade
|
| Investment in Securities | -203.98 | -231.96 | -83.02 | -482.99 | 75.67 | -158.17 | Upgrade
|
| Other Investing Activities | -423.24 | 13.3 | 13.97 | 13.63 | 7.82 | 4.13 | Upgrade
|
| Investing Cash Flow | -661.07 | -229.7 | -83.81 | -545.79 | 11.87 | -212.24 | Upgrade
|
| Short-Term Debt Issued | - | 102.84 | 90 | 236.24 | 171.51 | 330 | Upgrade
|
| Total Debt Issued | 40.04 | 102.84 | 90 | 236.24 | 171.51 | 330 | Upgrade
|
| Short-Term Debt Repaid | - | -20 | -170 | -130 | -286.51 | -395.5 | Upgrade
|
| Long-Term Debt Repaid | - | -1.89 | -2.28 | -1.68 | - | - | Upgrade
|
| Total Debt Repaid | -21.89 | -21.89 | -172.28 | -131.68 | -286.51 | -395.5 | Upgrade
|
| Net Debt Issued (Repaid) | 18.15 | 80.96 | -82.28 | 104.56 | -115 | -65.5 | Upgrade
|
| Issuance of Common Stock | - | - | - | 75.91 | - | - | Upgrade
|
| Repurchase of Common Stock | -0.79 | -0.79 | -1.85 | -184.5 | - | - | Upgrade
|
| Common Dividends Paid | -456.74 | -344.28 | -288.84 | -223.83 | -179.12 | -98.31 | Upgrade
|
| Other Financing Activities | 0.27 | -8.62 | -0.12 | -3.09 | -12.09 | -113.83 | Upgrade
|
| Financing Cash Flow | -439.1 | -272.73 | -373.09 | -230.94 | -306.2 | -277.65 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | -0 | 0.04 | -0.03 | -0.1 | 0.01 | Upgrade
|
| Net Cash Flow | -445.39 | 310.99 | 378.04 | 68.93 | 156.11 | -39.72 | Upgrade
|
| Free Cash Flow | 610.92 | 792.23 | 807.92 | 768.78 | 378.71 | 391.12 | Upgrade
|
| Free Cash Flow Growth | -27.86% | -1.94% | 5.09% | 103.00% | -3.17% | 1.82% | Upgrade
|
| Free Cash Flow Margin | 17.14% | 23.92% | 26.91% | 28.54% | 16.24% | 18.13% | Upgrade
|
| Free Cash Flow Per Share | 1.09 | 1.40 | 1.42 | 1.36 | 0.67 | 0.68 | Upgrade
|
| Cash Income Tax Paid | 458.63 | 476.55 | 395.21 | 356.59 | 314.51 | 308.35 | Upgrade
|
| Levered Free Cash Flow | 522.27 | 632.03 | 546.14 | 675.19 | 264.32 | 237.44 | Upgrade
|
| Unlevered Free Cash Flow | 522.27 | 632.15 | 546.85 | 676.38 | 265.01 | 243.67 | Upgrade
|
| Change in Net Working Capital | -26.44 | -188.68 | -251.62 | -441.28 | -65.88 | -27.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.